跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FEXODIN 180 fexofenadine hydrochloride 180 mg tablet blister (general sale) pack - TGA Drug Approval Details
Approvals
/
TGA
/
FEXODIN 180 fexofenadine hydrochloride 180 mg tablet blister (general sale) pack
Approved
STANDARD
FEXODIN 180 fexofenadine hydrochloride 180 mg tablet blister (general sale) pack
Nova Pharmaceuticals Australasia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
b49aca890f1de230
Company
Nova Pharmaceuticals Australasia Pty Ltd
Type
Standard
Approval Details
Approval Id
b49aca890f1de230
Product Name
FEXODIN 180 fexofenadine hydrochloride 180 mg tablet blister (general sale) pack
Artg Id
375020
Artg Name
FEXODIN 180 fexofenadine hydrochloride 180 mg tablet blister (general sale) pack
Sponsor
Nova Pharmaceuticals Australasia Pty Ltd
Company Detail Path
/organization/nova-pharmaceuticals-australasia-pty-ltd
Artg Date
2021-09-21
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
b49aca890f1de230
Type
Standard
Back to TGA Approvals
